Standard screening methods underreport AAV-mediated transduction and gene editing
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Standard screening methods underreport AAV-mediated transduction and gene editing
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-30
DOI
10.1038/s41467-019-11321-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- In Situ Modification of Tissue Stem and Progenitor Cell Genomes
- (2019) Jill M. Goldstein et al. Cell Reports
- Nephron segment-specific gene expression using AAV vectors
- (2018) Laureano D. Asico et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector
- (2018) Yoichiro Ikeda et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
- (2018) Ang Li et al. Molecular Therapy-Methods & Clinical Development
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
- (2015) Shin-Heng Chiou et al. GENES & DEVELOPMENT
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study
- (2014) C J Rocca et al. GENE THERAPY
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isolation of Murine Lymph Node Stromal Cells
- (2014) Maria A. S. Broggi et al. Jove-Journal of Visualized Experiments
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
- (2013) Dominik F. Aschauer et al. PLoS One
- A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype
- (2013) Brian L Ellis et al. Virology Journal
- Combined Paracrine and Endocrine AAV9 mediated Expression of Hepatocyte Growth Factor for the Treatment of Renal Fibrosis
- (2010) Stephanie Schievenbusch et al. MOLECULAR THERAPY
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
- (2009) Linda Madisen et al. NATURE NEUROSCIENCE
- Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and Rat
- (2008) Lawrence T. Bish et al. HUMAN GENE THERAPY
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started